EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biocontainment strategies for in vivo applications of Saccharomyces boulardii

Karl Alex Hedin, Vibeke Kruse, Ruben Vazquez-Uribe, Morten Otto Alexander Sommer

Frontiers in Bioengineering and Biotechnology · 20.02.2023 · 11

DOI: 10.3389/fbioe.2023.1136095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 20.02.2023. Verfasst von Karl Alex Hedin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs Lyngby, Denmark. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, H2020 Marie Skłodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human gastrointestinal tract is a complex and dynamic environment, playing a crucial role in human health. Microorganisms engineered to express a therapeutic activity have emerged as a novel modality to manage numerous diseases. Such advanced microbiome therapeutics (AMTs) must be contained within the treated individual. Hence safe and robust biocontainment strategies are required to prevent the proliferation of microbes outside the treated individual. Here we present the first biocontainment strategy for a probiotic yeast, demonstrating a multi-layered strategy combining an auxotrophic and environmental-sensitive strategy. We knocked out the genes THI6 and BTS1, causing thiamine auxotrophy and increased sensitivity to cold, respectively. The biocontained Saccharomyces boulardii showed restricted growth in the absence of thiamine above 1 ng/ml and exhibited a severe growth defect at temperatures below 20°C. The biocontained strain was well tolerated and viable in mice and demonstrated equal efficiency in peptide production as the ancestral non-biocontained strain. In combination, the data support that thi6 ∆ and bts1 ∆ enable biocontainment of S. boulardii, which could be a relevant chassis for future yeast-based AMTs.

Schlagwörter

Stichwörter der Autor:innen

S boulardiibiocontainmentbiosafetyengineered microbesgut micobiomeprobiotic yeast

Autor:innen und Institutionen

  • Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs Lyngby, Denmark.

Förderung

  • Novo Nordisk Fonden
  • H2020 Marie Skłodowska-Curie Actions

Zitieren

APA

Hedin, K. A., Kruse, V., Vazquez-Uribe, R., & Sommer, M. O. A. (2023). Biocontainment strategies for in vivo applications of Saccharomyces boulardii. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1136095

Vancouver

Hedin KA, Kruse V, Vazquez-Uribe R, Sommer MOA. Biocontainment strategies for in vivo applications of Saccharomyces boulardii. Frontiers in Bioengineering and Biotechnology. 2023;11. doi:10.3389/fbioe.2023.1136095

BibTeX
@article{Hedin2023,
  author = {Hedin, Karl Alex and Kruse, Vibeke and Vazquez-Uribe, Ruben and Sommer, Morten Otto Alexander},
  title = {Biocontainment strategies for in vivo applications of Saccharomyces boulardii},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fbioe.2023.1136095}
}
Kostenlos starten →